November 30, 2015 – Curant Health COO, Marc O’Connor, in Managed Healthcare Executive – This year, many new medications and treatments emerged to improve the management and prognoses of patients suffering from serious illnesses. But while these developments represent promise, they also raise complex decisions related to cost and quality. In 2016, as these developments play a larger role in health management and treatment, managed healthcare executives must be informed. Here’s a quick look at some of the latest developments in top therapeutic areas that should be on your radar.

1. Oncology

As new, more tailored and effective oral treatments emerge, the oncology drug category will be one to watch. “These [new treatments] will replace traditional IV therapies that took a more ‘shotgun approach,’ by treating general cancer types,” says Steve Liles, PharmD, senior director, pharmacy services at Goold Health Systems, an Emdeon Company.

To read the full article, visit Managed Healthcare Executive

To learn more about Curant Health, contact Kristin Lindsey, Marketing Director, at klindsey@curanthealth.com.